Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswireNov 9 05:15

Express News | Esperion Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BreakingsNov 9 05:15

Esperion Therapeutics Shares Are Trading Higher. The Stock May Be Moving on Continued Strength After Reporting Better-than-expected Q3 Financing Results Yesterday. Also, HC Wainwright & Co. Reiterated a Buy Rating on the Stock.

BenzingaNov 9 03:01

A Quick Look at Today's Ratings for Esperion Therapeutics(ESPR.US), With a Forecast Between $2.05 to $16

Futu NewsNov 8 21:00 · Ratings

Esperion Therapeutics | 10-Q: Quarterly report

SECNov 8 05:29 · Announcements

Esperion Therapeutics, Inc. (ESPR) Q3 2024 Earnings Call Transcript

Earnings Call TranscriptsNov 8 02:35